376 related articles for article (PubMed ID: 20141228)
1. The role of tetracyclines in rosacea.
Alikhan A; Kurek L; Feldman SR
Am J Clin Dermatol; 2010; 11(2):79-87. PubMed ID: 20141228
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflamatory dose doxycycline in the treatment of rosacea.
Del Rosso JQ
J Drugs Dermatol; 2009 Jul; 8(7):664-8. PubMed ID: 19588643
[TBL] [Abstract][Full Text] [Related]
3. Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea.
Fowler JF
J Drugs Dermatol; 2007 Jun; 6(6):641-5. PubMed ID: 17668530
[TBL] [Abstract][Full Text] [Related]
4. Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics.
Conde JF; Yelverton CB; Balkrishnan R; Fleischer AB; Feldman SR
J Drugs Dermatol; 2007 May; 6(5):495-8. PubMed ID: 17679183
[TBL] [Abstract][Full Text] [Related]
5. Clinical inquiries. What is the most effective treatment for acne rosacea?
May D; Kelsberg G; Safranek S
J Fam Pract; 2011 Feb; 60(2):108a-100c. PubMed ID: 21301648
[No Abstract] [Full Text] [Related]
6. Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial.
Del Rosso JQ
Cutis; 2010 Nov; 86(5 Suppl):16-25. PubMed ID: 21229827
[TBL] [Abstract][Full Text] [Related]
7. Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea.
Del Rosso JQ; Schlessinger J; Werschler P
J Drugs Dermatol; 2008 Jun; 7(6):573-6. PubMed ID: 18561589
[No Abstract] [Full Text] [Related]
8. Optimal management of papulopustular rosacea: rationale for combination therapy.
Bhatia ND; Del Rosso JQ
J Drugs Dermatol; 2012 Jul; 11(7):838-44. PubMed ID: 22777226
[TBL] [Abstract][Full Text] [Related]
9. Low-dose doxycycline (Oracea) for rosacea.
Med Lett Drugs Ther; 2007 Jan; 49(1252):5-6. PubMed ID: 17220813
[No Abstract] [Full Text] [Related]
10. Tetracycline actions relevant to rosacea treatment.
Korting HC; Schöllmann C
Skin Pharmacol Physiol; 2009; 22(6):287-94. PubMed ID: 19786821
[TBL] [Abstract][Full Text] [Related]
11. Doxycycline 40 mg capsules (30 mg immediate-release/10 mg delayed-release beads): anti-inflammatory dose in rosacea.
McKeage K; Deeks ED
Am J Clin Dermatol; 2010; 11(3):217-22. PubMed ID: 20369903
[TBL] [Abstract][Full Text] [Related]
12. Subantimicrobial dose doxycycline: a unique treatment for rosacea.
Berman B; Zell D
Cutis; 2005 Apr; 75(4 Suppl):19-24. PubMed ID: 15916226
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea.
Sanchez J; Somolinos AL; Almodóvar PI; Webster G; Bradshaw M; Powala C
J Am Acad Dermatol; 2005 Nov; 53(5):791-7. PubMed ID: 16243127
[TBL] [Abstract][Full Text] [Related]
14. Subantimicrobial dose doxycycline for acne and rosacea.
Bikowski JB
Skinmed; 2003; 2(4):234-45. PubMed ID: 14673277
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea.
Del Rosso JQ; Bruce S; Jarratt M; Menter A; Staedtler G
J Drugs Dermatol; 2010 Jun; 9(6):607-13. PubMed ID: 20645521
[TBL] [Abstract][Full Text] [Related]
16. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.
Thiboutot DM; Fleischer AB; Del Rosso JQ; Rich P
J Drugs Dermatol; 2009 Jul; 8(7):639-48. PubMed ID: 19588640
[TBL] [Abstract][Full Text] [Related]
17. Update on rosacea and anti-inflammatory-dose doxycycline.
Berman B; Perez OA; Zell D
Drugs Today (Barc); 2007 Jan; 43(1):27-34. PubMed ID: 17315050
[TBL] [Abstract][Full Text] [Related]
18. Current topical and systemic approaches to treatment of rosacea.
Korting HC; Schöllmann C
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):876-82. PubMed ID: 19508315
[TBL] [Abstract][Full Text] [Related]
19. Rosacea: where are we now?
Bikowski JB; Goldman MP
J Drugs Dermatol; 2004; 3(3):251-61. PubMed ID: 15176158
[TBL] [Abstract][Full Text] [Related]
20. Emerging therapies in rosacea.
Layton A; Thiboutot D
J Am Acad Dermatol; 2013 Dec; 69(6 Suppl 1):S57-65. PubMed ID: 24229638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
